Though some preclinical research indicates Dihexa may help form new functional synaptic connections and improve memory retention, formal large-scale human trials are still needed
According to clinical trials, adults with type 2 diabetes taking the highest dose of tirzepatide (15 mg) achieved an A1C reduction of 2.46 percent and a weight loss of about 13 percent over 40 weeks
The elevated risk persisted at 12 months, increasing from 13.6% to 14.3%
A small subset warrant a same-day call
Semaglutide targets GLP-1 only
Certain factors may increase susceptibility to burping and related gastrointestinal symptoms, including: Rapid dose escalation (not following the recommended titration schedule) Concurrent use of other medications affecting gut motility (such as opioids or anticholinergics) Pre-existing gastrointestinal conditions such as gastroparesis or gastroesophageal reflux disease (GERD) Dietary habits that promote gas production Gastrointestinal adverse effects, including burping, are generally more common and pronounced at higher doses, which explains the higher rates observed with Wegovy compared to Ozempic